Home > Healthcare > Medical Devices > Diagnostic Devices > Autoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market Share

Report ID: GMI618
Published Date: Sep 2024
Report Format: PDF

Download Free Sample

Autoimmune Disease Diagnostics Market Share

The global market is highly competitive, characterized by rapid advancements in diagnostic technologies and a growing focus on early detection. Market players are continuously innovating to improve the accuracy, efficiency, and accessibility of diagnostic tests. The landscape is shaped by frequent product launches, strategic partnerships, and mergers and acquisitions aimed at expanding market presence. Additionally, increased investment in research and development, along with rising awareness of autoimmune diseases, is driving competition. The market is also influenced by regional expansions and the adoption of automation in diagnostic processes, further intensifying the competitive environment.

Autoimmune Disease Diagnostics Market Companies

Some of the eminent market participants operating in the autoimmune disease diagnostics industry include:

Abbott Laboratories
Bio-Rad Laboratories, Inc.
DIAsource ImmunoAssays SA
Euroimmun AG (Perkin Elmer)
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics
Myriad Genetics
Quest Diagnostics
Siemens Healthineers Inc
SQI Diagnostics Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech Plc.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The autoimmune disease diagnostics industry was valued at USD 5.3 billion in 2023 and is anticipated to witness 5.9% CAGR from 2024 to 2032, led by rising incidence of autoimmune diseases and the adoption of automation in equipment

The hospitals end-use segment accounted for 53.5% of the market share in 2023 owing to the surged adoption of autoimmune disease diagnostic procedures in hospitals associated to complex interventional surgeries.

North America autoimmune disease diagnostics industry size was USD 1.9 billion in 2023 attributed to rising autoimmune disease burden, and increasing healthcare expenditure

Abbott Laboratories, Bio-Rad Laboratories, Inc., DIAsource ImmunoAssays SA, Euroimmun AG (Perkin Elmer), F. Hoffmann-la Roche Ltd., Hemagen Diagnostics, Myriad Genetics, Quest Diagnostics, Siemens Healthineers Inc., SQI Diagnostics Inc., and Thermo Fisher Scientific Inc.